Senior insider sale
Chief Commercial Officer at SPRINGWORKS THERAPEUTICS, INC. — senior position signals high conviction
$987.6K
16.09K shares
What this filing means
ASHAR BHAVESH plans to sell 16.09K shares of SPRINGWORKS THERAPEUTICS, INC. valued at approximately $987.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/20/2025ACC: 0001968582-25-000109
Officer· Chief Commercial Officer
Since Mar 2021
16.09K
Shares to sell
$987.6K
Approx. market value
16.09K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months6
Stock Option Exercise
Cash
2/20/2025
13.04KRestricted Stock Award
NA
1/5/2025
1.01KRestricted Stock Award
NA
1/4/2025
503.00Restricted Stock Award
NA
4/1/2024
364.00Restricted Stock Award
NA
1/6/2024
783.00Restricted Stock Award
NA
1/5/2024
392.00Total acquired16.09K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/20/2025 | Stock Option Exercise Cash | 13.04K | — |
1/5/2025 | Restricted Stock Award NA | 1.01K | — |
1/4/2025 | Restricted Stock Award NA | 503.00 | — |
4/1/2024 | Restricted Stock Award NA | 364.00 | — |
1/6/2024 | Restricted Stock Award NA | 783.00 | — |
1/5/2024 | Restricted Stock Award NA | 392.00 | — |
| Total | 16.09K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
16.09K
Market value
$987.6K
2/20/2025
Total
Units
16.09K
Value
$987.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/20/2025 | 16.09K | $987.6K | Nasdaq | Planned |
| Total | 16.09K | $987.6K | ||